colforsin has been researched along with 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3h)-one in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glenn, J; Hardy, E; Heptinstall, S; Horn, EH; Rubin, PC | 1 |
| Glenn, JR; Heptinstall, S | 1 |
| Glenn, JR; Heptinstall, S; Iyu, D; White, AE | 1 |
3 other study(ies) available for colforsin and 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3h)-one
| Article | Year |
|---|---|
Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP.
Topics: Blood Platelets; Colforsin; Cyclic AMP; Drug Interactions; Female; Humans; Iloprost; Magnesium; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin D2; Quinazolines; Signal Transduction | 1995 |
Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Colforsin; Cyclic AMP; Enzyme Activation; Humans; Iloprost; Magnesium; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Receptors, Purinergic P2; Reference Values | 1998 |
PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors.
Topics: Acrylamides; Blood Platelets; Cell Adhesion Molecules; Colforsin; Cyclic AMP; Dinoprostone; Humans; Microfilament Proteins; Naphthalenes; Phenylbutyrates; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Antagonists; Quinazolines; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfones | 2012 |